T R Andersson
Overview
Explore the profile of T R Andersson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andersson T, Sie P, Pelzer H, Aamodt L, Nustad K, Abildgaard U
Thromb Res
. 1992 Jun;
66(5):591-8.
PMID: 1523613
An ELISA assay for quantitation of the thrombin-heparin cofactor II complex (T-HC II) in plasma was developed. Plasma was incubated with immobilized, specific antibodies to human thrombin. The second, biotinylated...
2.
Wisloff F, Andersen P, Andersson T, Brandt E, Eika C, Fjaestad K, et al.
Eur J Haematol
. 1991 Nov;
47(5):338-41.
PMID: 1761119
During a general population follow-up study in Health Region I in Norway, 162 patients with multiple myeloma (MM) were diagnosed. 71 of these (44%) were asymptomatic, and were observed without...
3.
Wisloff F, Andersen P, Andersson T, Brandt E, Eika C, Fjaestad K, et al.
Eur J Haematol
. 1991 Nov;
47(5):333-7.
PMID: 1761118
All patients in the region with newly discovered M components were registered from 15 Aug. 1984-31 Dec. 1986. Among a total of 393 patients enrolled, 162 had multiple myeloma (MM)....
4.
Sandset P, Hogevold H, Lyberg T, Andersson T, Abildgaard U
Thromb Haemost
. 1989 Nov;
62(3):856-60.
PMID: 2595660
Extrinsic coagulation pathway inhibitor may be an important regulator of haemostasis to prevent thrombosis after tissue damage. The functional activity of this inhibitor was determined using a chromogenic substrate assay,...
5.
Lindahl A, Sandset P, Abildgaard U, Andersson T, HARBITZ T
Acta Chir Scand
. 1989 Aug;
155(8):389-93.
PMID: 2596246
Serial determinations of plasma coagulation inhibitor levels were performed with chromogenic substrate activity assays in 7 patients with cancer. At time of diagnosis normal median activities of Antithrombin, Protein C,...
6.
Sandset P, Andersson T
J Intern Med
. 1989 May;
225(5):311-6.
PMID: 2471768
The well-known coagulation inhibitors antithrombin and protein C, and the more recently described inhibitors, heparin cofactor II and extrinsic pathway inhibitor, were measured in plasma during a 7-day observation period,...
7.
Blinder M, Andersson T, Abildgaard U, Tollefsen D
J Biol Chem
. 1989 Mar;
264(9):5128-33.
PMID: 2647747
Heparin and dermatan sulfate increase the rate of inhibition of thrombin by heparin cofactor II (HCII) approximately 1000-fold by providing a catalytic template to which both the inhibitor and the...
8.
Andersson T, Bell H
J Hepatol
. 1988 Aug;
7(1):79-84.
PMID: 3183355
The coagulation inhibitor heparin cofactor II (HC II) was measured in various liver diseases and compared with antithrombin (AT), Normotest (NT), albumin and bilirubin. The lowest mean HC II level...
9.
Andersson T, Bangstad H, Larsen M
Acta Paediatr Scand
. 1988 Jul;
77(4):485-8.
PMID: 3394503
The coagulation inhibitors heparin cofactor II (HC II), antithrombin (AT) and protein C (PC) were measured in healthy term and preterm infants in order to establish reference standards. The mean...
10.
Abildgaard U, Sandset P, Andersson T, Odegaard O, Rosen S
Folia Haematol Int Mag Klin Morphol Blutforsch
. 1988 Jan;
115(3):274-7.
PMID: 2465215
The plasma inhibitor(s) of factor VIIa-tissue thromboplastin cooperates with factor Xa. This "Extrinsic Pathway Inhibitor" has been quantitated with a sensitive chromogenic substrate assay. Gel filtration of plasma separates 3...